Centers | ||
|
|
|
DRSC at Harvard Medical School | BLAVATNIK CENTER for Drug Discovery | Pharmaceutical Sciences |
Originally founded in 2003 to support RNAi screening in Drosophila cells, the DRSC has grown to include support for functional genomics screens in fly cells and in vivo, as well as for a number of bioinformatics analyses and visualization relevant to... |
The BLAVATNIK CENTER for Drug Discovery (BCDD) is a fully integrated center for translational research, based at Tel Aviv University, that comprises medicinal chemistry, biological target identification and computer-assisted drug design units under... Read more |
With strengths in structure-based drug design our expertise in physical, computational, synthetic, and protein chemistry cuts across several centers of excellence in Computer Aided Drug Design, Nuclear Magnetic Resonance (NMR), and Mass Spectrometry.... |
Partnerships |
Events |
Jobs |
||
Astra Zeneca and Broad Institute to Co-develop Antiviral and Antibacterial DrugsBroad Institute and Astrza Zeneca have entered into a two year collaboration agreement to co-develop antiviral and antibacterial drugs. Screening and target hit to lead chemistry will take place at Broad while Astra Zeneca will be responsible for... View all CEOdevelopment of peptide therapeutics to metastatic cancer View all Sanofi and MIT Form New Partnership to Foster Industry - Academic CollaborationSanofi and MIT's Center for Biomedical Innovation has established a new partnership to foster basic and applied research and develop solutions to address unmet clinical needs. Sanofi will be providing funding to support specific research projects... View all |
Join us for breakfast, lunch, or cocktails in your local time zone for our monthly webinar... 
The 2022 offering of the Training in Neurotherapeutics Discovery and Development for... 28 March, 2022 |
Assistant Scientist Medicinal Chemist
... 01 October, 2021 Learn More Scientist Ph.D. Medicinal Chemist ... 01 October, 2021 Learn More View more Jobs |
